Abstract: The present invention provides a fermented honey product obtained by fermenting a honey-containing material having a honey concentration of more than 25% with Lactobacillus kunkeei.

Abstract: The present invention provides a mucosal immunomodulator comprising, as an active ingredient, at least one selected from the group consisting of compounds represented by the following formula (1), compounds represented by the following formula (2) and compounds represented by the following formula (3), and salts thereof.

Abstract: The present invention provides a honey fraction obtainable by a method comprising (a) obtaining an absorbed component by causing honey to be brought into contact with an adsorbent, (b) obtaining an organic solvent fraction by eluting the absorbed component with an organic solvent that is acetone, ethyl acetate, or ethanol, and (c) obtaining a honey fraction from the organic solvent fraction.

Abstract: The present invention provides a fermented product obtained by fermenting honey and camomile or a treated product thereof with Lactobacillus kunkeei.

Abstract: Disclosed is a genome stability enhancer comprising, as an active ingredient, at least one member selected from the group consisting of enzyme-treated royal jelly, gnetum or its extract, and gnetin C.

Abstract: Disclosed are: a lactic acid bacterium belonging to Lactobacillus kunkeei, the bacterium having a higher IgA production inducing activity than that of Lactobacillus strain GG (ATCC53103), and a lower mitogenic activity and a lower IL-2 production inducing activity than those of Listeria strain EGD; and a food composition, a pharmaceutical composition, a cosmetic composition, an immunostimulant for preventing the infection by pathogens or viruses that invade through the respiratory or esophageal mucosa, and an intestinal immunostimulant for preventing or alleviating food poisoning, each of which contains the lactic acid bacterium or treated cells of the lactic acid bacterium.

Abstract: The present invention provides a composition comprising: honey; bee pollen; royal jelly; and propolis, wherein the content of the honey is 70% by mass or more and less than 100% by mass relative to the whole amount of the composition; the content of the bee pollen is more than 0% by mass and 10% by mass or less in terms of solid content relative to the whole amount of the composition; the content of the royal jelly is more than 0% by mass and 10% by mass or less in terms of solid content relative to the whole amount of the composition; and the content of the propolis is more than 0% by mass and 10% by mass or less in terms of solid content relative to the whole amount of the composition.

Abstract: The present invention provides a blood flow-improving agent comprising 10-hydroxydecanoic acid as an active ingredient.

Abstract: Disclosed are: a lactic acid bacterium belonging to Lactobacillus kunkeei, the bacterium having a higher IgA production inducing activity than that of Lactobacillus strain GG (ATCC53103), and a lower mitogenic activity and a lower IL-2 production inducing activity than those of Listeria strain EGD; and a food composition, a pharmaceutical composition, a cosmetic composition, an immunostimulant for preventing the infection by pathogens or viruses that invade through the respiratory or esophageal mucosa, and an intestinal immunostimulant for preventing or alleviating food poisoning, each of which contains the lactic acid bacterium or treated cells of the lactic acid bacterium.

Abstract: The present invention provides an unsaturated fatty acid absorption accelerator comprising a wax as an active ingredient. The absorption of unsaturated fatty acids can be accelerated by using the absorption accelerator of the present invention.